Results 101 to 110 of about 686,514 (182)
Abstract Objectives To evaluate the effectiveness and cost‐effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school‐aged children living in communities where the burden of malaria and helminths is high in Ghana, West Africa.
Muhammed O. Afolabi +6 more
wiley +1 more source
Malaria chemoprevention and drug resistance
This report was considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2 Preventive chemotherapies” of the WHO Guidelines for malaria, 3 June 2022.Review subsequently published on 24 March 2022 in Malaria Journal:
Plowe C
core +1 more source
Artesunate–amodiaquine (ARS–AQ) is a first‐line antimalarial treatment recommended by the World Health Organization. AQ is the long acting partner drug in this combination, and therapeutic success is correlated with the terminal exposure to AQ. Dried blood spot (DBS) sampling for AQ is a convenient and minimally invasive technique, especially suitable ...
Natpapat Kaewkhao +3 more
wiley +1 more source
Malaria Prevention Strategies in South Sudan
The whole of South Sudan is endemic for malaria, with high transmission in the country throughout the year. Malaria is the leading cause of illness and death in children under five years. In 2019, the malaria incidence (all ages) was estimated at 246 per
Harriet Akello Pasquale
doaj
BackgroundSeasonal Malaria Chemoprevention (SMC) is currently recommended for children under five in areas where malaria transmission is highly seasonal.
Gifty D Antwi +6 more
doaj +1 more source
Background Seasonal malaria chemoprevention (SMC) is a highly effective intervention for malaria prevention in high burden areas with seasonal transmission, historically implemented in the Sahel.
Kevin Baker +14 more
doaj +1 more source
Sulfadoxine-pyrimethamine (SP) is a key antimalarial used in chemoprevention strategies, including intermittent preventive treatment in pregnancy (IPTp); intermittent preventive treatment in infants (IPTi); seasonal malaria chemoprevention (SMC); and ...
Nicholaus Mziray +6 more
doaj +1 more source
Malaria expert Dr. Paul Milligan discusses the benefits of seasonal malaria chemoprevention and how up to 80% of malaria cases can be prevented in high-risk communities.
LSHTM
core +2 more sources
A summary of the health districts and population in the countries of the Nouakchott Initiative for targeting of seasonal malaria chemoprevention (SMC) in the Sahel from 2015–2020.
Bernard Mitto (790270) +5 more
core +1 more source
This systematic review aims to To systematically synthesize evidence on (i) the association between nutritional status and malaria-related outcomes and (ii) the impact of nutritional interventions among children aged 3-59 months receiving SP-AQ-based ...
Nafomon Sogoba +16 more
core +1 more source

